528 related articles for article (PubMed ID: 19692457)
21. Protective effect of A/H1N1 vaccination in immune-mediated disease--a prospectively controlled vaccination study.
Adler S; Krivine A; Weix J; Rozenberg F; Launay O; Huesler J; Guillevin L; Villiger PM
Rheumatology (Oxford); 2012 Apr; 51(4):695-700. PubMed ID: 22171015
[TBL] [Abstract][Full Text] [Related]
22. Patients with humoral primary immunodeficiency do not develop protective anti-influenza antibody titers after vaccination with trivalent subunit influenza vaccine.
van Assen S; Holvast A; Telgt DS; Benne CA; de Haan A; Westra J; Kallenberg CG; Bijl M
Clin Immunol; 2010 Aug; 136(2):228-35. PubMed ID: 20421178
[TBL] [Abstract][Full Text] [Related]
23. Autoantibody response to adjuvant and nonadjuvant H1N1 vaccination in systemic lupus erythematosus.
Urowitz MB; Anton A; Ibanez D; Gladman DD
Arthritis Care Res (Hoboken); 2011 Nov; 63(11):1517-20. PubMed ID: 22034113
[TBL] [Abstract][Full Text] [Related]
24. Serological response to the 2009 H1N1 influenza vaccination in patients with inflammatory bowel disease.
Cullen G; Bader C; Korzenik JR; Sands BE
Gut; 2012 Mar; 61(3):385-91. PubMed ID: 21757451
[TBL] [Abstract][Full Text] [Related]
25. Lack of effect of a booster dose of influenza vaccine in hemodialysis patients.
Tanzi E; Amendola A; Pariani E; Zappa A; Colzani D; Logias F; Perego A; Zanetti AR
J Med Virol; 2007 Aug; 79(8):1176-9. PubMed ID: 17596830
[TBL] [Abstract][Full Text] [Related]
26. Improved antibody responses in infants less than 1 year old using intradermal influenza vaccination.
Sugimura T; Ito Y; Tananari Y; Ozaki Y; Maeno Y; Yamaoka T; Kudo Y
Vaccine; 2008 May; 26(22):2700-5. PubMed ID: 18436353
[TBL] [Abstract][Full Text] [Related]
27. Is there a benefit from an early booster vaccination in the control of equine influenza?
Heldens JG; van Loon AA; van de Zande S
Vet J; 2007 Nov; 174(3):592-8. PubMed ID: 17560150
[TBL] [Abstract][Full Text] [Related]
28. Flu: effect of vaccine in elderly care home residents: a randomized trial.
Gaughran F; Walwyn R; Lambkin-Williams R; Whelan P; Chatterton K; Oxford J; Macdonald A;
J Am Geriatr Soc; 2007 Dec; 55(12):1912-20. PubMed ID: 18081669
[TBL] [Abstract][Full Text] [Related]
29. Influenza vaccination in systemic lupus erythematosus: safe and protective?
Holvast B; Huckriede A; Kallenberg CG; Bijl M
Autoimmun Rev; 2007 Apr; 6(5):300-5. PubMed ID: 17412302
[TBL] [Abstract][Full Text] [Related]
30. Rapid decline of influenza vaccine-induced antibody in the elderly: is it real, or is it relevant?
Skowronski DM; Tweed SA; De Serres G
J Infect Dis; 2008 Feb; 197(4):490-502. PubMed ID: 18275271
[TBL] [Abstract][Full Text] [Related]
31. Effective immunization against influenza in pediatric renal transplant recipients.
Edvardsson VO; Flynn JT; Deforest A; Kaiser BA; Schulman SL; Bradley A; Palmer J; Polinsky MS; Baluarte HJ
Clin Transplant; 1996 Dec; 10(6 Pt 1):556-60. PubMed ID: 8996778
[TBL] [Abstract][Full Text] [Related]
32. Safety and efficacy of a novel microneedle device for dose sparing intradermal influenza vaccination in healthy adults.
Van Damme P; Oosterhuis-Kafeja F; Van der Wielen M; Almagor Y; Sharon O; Levin Y
Vaccine; 2009 Jan; 27(3):454-9. PubMed ID: 19022318
[TBL] [Abstract][Full Text] [Related]
33. Influenza virus vaccination of patients with SLE: effects on generation of autoantibodies.
Abu-Shakra M; Press J; Sukenik S; Buskila D
Clin Rheumatol; 2002 Sep; 21(5):369-72. PubMed ID: 12223983
[TBL] [Abstract][Full Text] [Related]
34. Influenza A/H1N1 vaccination of patients with SLE: can antimalarial drugs restore diminished response under immunosuppressive therapy?
Borba EF; Saad CG; Pasoto SG; Calich AL; Aikawa NE; Ribeiro AC; Moraes JC; Leon EP; Costa LP; Guedes LK; Silva CA; Goncalves CR; Fuller R; Oliveira SA; Ishida MA; Precioso AR; Bonfa E
Rheumatology (Oxford); 2012 Jun; 51(6):1061-9. PubMed ID: 22298793
[TBL] [Abstract][Full Text] [Related]
35. Immunogenicity and Safety of Influenza Vaccination in Systemic Lupus Erythematosus Patients Compared with Healthy Controls: A Meta-Analysis.
Liao Z; Tang H; Xu X; Liang Y; Xiong Y; Ni J
PLoS One; 2016; 11(2):e0147856. PubMed ID: 26845680
[TBL] [Abstract][Full Text] [Related]
36. Immunogenicity and safety of low dose virosomal adjuvanted influenza vaccine administered intradermally compared to intramuscular full dose administration.
Künzi V; Klap JM; Seiberling MK; Herzog C; Hartmann K; Kürsteiner O; Kompier R; Grimaldi R; Goudsmit J
Vaccine; 2009 Jun; 27(27):3561-7. PubMed ID: 19464535
[TBL] [Abstract][Full Text] [Related]
37. Subunit influenza vaccines produced from cell culture or in embryonated chicken eggs: comparison of safety, reactogenicity, and immunogenicity.
Reisinger KS; Block SL; Izu A; Groth N; Holmes SJ
J Infect Dis; 2009 Sep; 200(6):849-57. PubMed ID: 19673652
[TBL] [Abstract][Full Text] [Related]
38. Influenza revaccination of elderly travelers: antibody response to single influenza vaccination and revaccination at 12 weeks.
Buxton JA; Skowronski DM; Ng H; Marion SA; Li Y; King A; Hockin J
J Infect Dis; 2001 Jul; 184(2):188-91. PubMed ID: 11424016
[TBL] [Abstract][Full Text] [Related]
39. H1N1 vaccination in pediatric renal transplant patients.
Kelen K; Ferenczi D; Jankovics I; Varga M; Molnar MZ; Sallay P; Reusz G; Langer RM; Pasti K; Gerlei Z; Szabo AJ
Transplant Proc; 2011 May; 43(4):1244-6. PubMed ID: 21620100
[TBL] [Abstract][Full Text] [Related]
40. Impaired response rates, but satisfying protection rates to influenza vaccination in dialysis patients.
Vogtländer NP; Brown A; Valentijn RM; Rimmelzwaan GF; Osterhaus AD
Vaccine; 2004 Jun; 22(17-18):2199-201. PubMed ID: 15149777
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
